Study of drug utilization pattern in the department of radiotherapy in a tertiary care teaching hospital

Chandan N. G.; Ranganathan T.; Nagabushan H.

doi:10.18203/2319-2003.ijbcp20191581

Authors

Chandan N. G. Department of Pharmacology, Mandya Institute of Medical Sciences, Mandya, Karnataka, India
Ranganathan T. Department of Radiotherapy, Mandya Institute of Medical Sciences, Mandya, Karnataka, India
Nagabushan H. Department of Pharmacology, Mandya Institute of Medical Sciences, Mandya, Karnataka, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20191581

Keywords:

Drug utilization studies, Essential drugs, Radiotherapy, WHO prescribing indicators

Abstract

Background: Drug utilization studies are an important tool in evaluating the rationality of therapeutic practice and also it is said to improvise the therapeutic use of drugs. The present study will be undertaken to evaluate the drug utilization pattern in the department of Radiotherapy.

Methods: This was a prospective, observational study that was undertaken in the department of Radiotherapy in a tertiary care teaching hospital. The study was conducted for a period of 6 months after obtaining permission from Institutional Ethical Committee. The study was conducted among cancer patients undergoing radiotherapy. The data was collected from the patient case records and was analyzed as per the WHO prescribing indicators.

Results: In the present study it was observed that the average number of drugs prescribed per encounter was 7.7. The drugs prescribed by generic name were 41.4%. Percentage of encounters with an antibiotic prescribed was 100. Percentage of encounters with an injection prescribed was 20.5%. Percentage of drugs prescribed from essential drugs list was 35.8%.

Conclusions: Drug utilization studies helps in modifying the prescription pattern and helps in making the drug usage more rational.

Metrics

Metrics Loading ...

References

Kumar V, Abbas AK, Aster JC. Robbin’s basic pathology. 10th ed. Philadelphia: Elsevier Saunders; 2018:189-242.

Cancer. Available at: https://www.who.int/en/news-room/fact-sheets/detail/cancer. Accessed 30 January 2018.

Cancer. Available at: https://www.who.int/cancer/resources/keyfacts/en/. Accessed 30 Janyary 2018.

Aliyu UM, Jimoh AO, Yunusa A, Umar M. Pattern of Cancers Treated with Radiotherapy in Uduth Sokoto: A New Center Experience. J Clin Diagn Res. 2015;9(8):XC01-4.

Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9(3):193-9.

Yoshimura M, Itasaka S, Harada H, Hiraoka M. Microenvironment and radiation therapy. BioMed research international. 2012;2013.

West CM, Barnett GC. Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med. 2011;3(8):52.

Berkey FJ. Managing the adverse effects of radiation therapy. Am Fam Physician. 2010;82(4):381-88.

Shalini S, Ravichandran V, Mohanty BK, Dhanaraj SK, Saraswathi R. Drug utilization studies – An overview. Int J Pharmaceut Sci Nanotechnol. 2010;3(1):803-10.

How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators - EDM Research Series No. 007: Chapter 2: Core drug use indicators: Group 1: Prescribing indicators. Available at: http://apps.who.int/medicinedocs/en/d/Js2289e/3.html. Accessed 22 December 2018.

Rodrigues MCS, Oliveira C. Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review. Rev Latino-Am Enfermagem. 2016;24:e2800.

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017 Dec;17(1):230.

Cameron A, Laing R. Cost savings of switching private sector consumption from originator brand medicines to generic equivalents. World Health Report. 2010;35:210-5.

Bera A, Mukherjee A. The importance of generic drugs in India. Int J Pharm Chem Biol Sci. 2012;2(4):575-87.

Gupta YK, Ramachandran SS. Fixed dose drug combinations: Issues and challenges in India. Indian J Pharmacol. 2016 Jul;48(4):347.

National List of Essential Medicine. 2015. Available at: http://cdsco.nic.in/WriteReadData/NLEM-2015/NLEM,%202015.pdf Accessed 22 December 2018.

Bansal D, Purohit VK. Accessibility and use of essential medicines in health care: Current progress and challenges in India. J Pharmacol Pharmacotherapeut. 2013 Jan;4(1):13.

Sneha G, Aparna S, Sri Lakshmi BNVB, Varma AS, Naidu DSR. Adjunctive Drug Utilization Pattern in Oncology Department of A Teritiary Care Hospital in South India. Indo Am J Pharm Res. 2015:5(03).

Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharma Therapeut. 2015;40(4):277.

WHO's cancer pain ladder for adults. Available at: https://www.who.int/cancer/palliative/painladder/en/. Accessed 21 December 2018.

Bostrom A, Lindman H, Swartling C, Berne B, Bergh J. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiother Oncol. 2001;59(3):257-65.

Ulff E, Maroti M, Serup J, Falkmer U. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams. Radiother Oncol. 2013;108(2):287-92.

Yonova D. Pruritus in certain internal diseases. Hippokratia. 2007 Apr;11(2):67.